Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT00800345
Title Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Accelerated Community Oncology Research Network

female reproductive organ cancer


Pazopanib + Topotecan

Age Groups: adult
Covered Countries USA

No variant requirements are available.